|

The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis

RECRUITINGN/ASponsored by Kutahya Health Sciences University
Actively Recruiting
PhaseN/A
SponsorKutahya Health Sciences University
Started2026-03-15
Est. completion2027-06-30
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted

Summary

This interventional clinical trial aims to investigate the effects of internal and external focus-based exercise training combined with cognitive dual-task training in individuals diagnosed with multiple sclerosis. The primary objective is to determine whether these exercise approaches improve gait, balance, and cognitive functions. The main research questions are: Does dual-task training combined with internal focus-based exercises improve gait, balance, and cognitive performance? Does dual-task training combined with external focus-based exercises lead to greater improvements compared to internal focus strategies? Participants will be divided into two groups, and the researchers will compare the effects of internal focus-based and external focus-based dual-task exercise training on functional outcomes. Participants will: Perform structured exercise sessions under the supervision of a physiotherapist Engage in dual-task activities by combining motor exercises with simple cognitive tasks (e.g., backward counting, word generation) Participate in an 8-week training program, with sessions held twice a week lasting approximately 45-60 minutes Undergo assessments of gait, balance, and cognitive function before and after the intervention This study does not involve invasive procedures or biological sample collection. The findings are expected to contribute to the development of more effective dual-task rehabilitation strategies for individuals with multiple sclerosis.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Multiple Sclerosis according to the revised McDonald criteria
* Aged between 20 and 60 years
* Ability to understand and follow simple instructions
* Ability to stand and walk independently or with an assistive device
* Ability to speak and understand Turkish
* Score of ≥21 on the Montreal Cognitive Assessment (MoCA)
* Willingness to participate in the study

Exclusion Criteria:

* MS relapse within the last 30 days
* Presence of any other neurological disease besides Multiple Sclerosis
* Any musculoskeletal condition that may affect walking or balance
* History of uncontrolled cardiorespiratory conditions within the last 3 months (e.g., hypertension, arrhythmia, tachycardia, or acute cardiopulmonary events)
* Severe visual or hearing impairment

Conditions1

Multiple Sclerosis

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.